STEVENS CAPITAL MANAGEMENT LP

Position in GILD — Gilead Sciences, Inc.

CIK 1134813 RADNOR, PA

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$801,753

-$4,308,465 QoQ

Shares Held

6,346

-86.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#1,163

of 2,266 holders

Holding Since

Jun 2020

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STEVENS CAPITAL MANAGEMENT LP holds $7,554,742 across 5 Drug Manufacturers - General names. GILD ranks #3 (10.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,749	$3,297,233
2	PFE	Pfizer Inc	85,193	$2,051,447
3	GILD	Gilead Sciences, Inc. This page	6,346	$801,753
4	JNJ	Johnson & Johnson	3,007	$763,687
5	NVO	Novo Nordisk A S	13,363	$640,622

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$801,753	6,346	-86.2%	Shares	Sole	2026-08-11
2025-09-30	$5,110,218	46,038	+248.9%	Shares	Sole	2025-11-10
2024-03-31	$966,607	13,196	-9.9%	Shares	Sole	2024-05-08
2022-03-31	$871,001	14,651	+21.5%	Shares	Sole	2022-05-13
2021-03-31	$779,114	12,055	-80.4%	Shares	Sole	2021-05-11
2020-06-30	$4,741,504	61,626	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.